Search Within

Jaclyn Frances Hechtman

  1. "Computational Oncology Service"
Formats
  1. Journal Article (27)
  2. Meeting Abstract (23)
Groups
  1. Computational Oncology Service (50)
  2. Epidemiology and Biostatistics (50)
  3. GSK Faculty (50)
  4. Department of Medicine (48)
  5. Human Oncology and Pathogenesis Program (48)
  6. Solid Tumor Oncology Division (48)

More Groups

People
  1. Nikolaus Schultz (47)
  2. David Solit (35)
  3. Michael Berger (30)
  4. Yelena Janjigian (24)
  5. Walid Chatila (21)
  6. Geoffrey Ku (20)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (4)
  4. 2020 (4)
  5. 2019 (13)
  6. 2018 (11)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Clinical Cancer Research (7)
  3. Annals of Oncology (3)
  4. JCO Precision Oncology (3)
  5. Modern Pathology (3)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (9)
  3. Nature Publishing Group (4)
  4. Oxford University Press (4)
  5. Nature Research (3)
  6. American Medical Association (2)

More Publishers

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
    Journal Article

    Chatila, W. K.; Walch, H.; Hechtman, J. F.; Moyer, S. M.; Sgambati, V.; Faleck, D. M.; Srivastava, A.; Tang, L.; Benhamida, J.; Ismailgeci, D.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Same-cell co-occurrence of RAS hotspot and BRAF V600E mutations in treatment-naive colorectal cancer
    Journal Article

    Gularte-MeĢrida, R.; Smith, S.; Bowman, A. S.; da Cruz Paula, A.; Chatila, W.; Bielski, C. M.; Vyas, M.; Borsu, L.; Zehir, A.; Martelotto, L. G.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Defining and targeting esophagogastric cancer genomic subsets with patient-derived xenografts
    Journal Article

    Moy, R. H.; Walch, H. S.; Mattar, M.; Chatila, W. K.; Molena, D.; Strong, V. E.; Tang, L. H.; Maron, S. B.; Coit, D. G.; Jones, D. R.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Genetic determinants of outcome in intrahepatic cholangiocarcinoma
    Journal Article

    Boerner, T.; Drill, E.; Pak, L. M.; Nguyen, B.; Sigel, C. S.; Doussot, A.; Shin, P.; Goldman, D. A.; Gonen, M.; Allen, P. J.; more...
    Hepatology (2021)

    Fulltext@MSK | Save
  • Prevalence of germline alterations on targeted tumor-normal sequencing of esophagogastric cancer
    Journal Article

    Ku, G. Y.; Kemel, Y.; Maron, S. B.; Chou, J. F.; Ravichandran, V.; Shameer, Z.; Maio, A.; Won, E. S.; Kelsen, D. P.; Ilson, D. H.; more...
    JAMA Network Open (2021)

    Fulltext@MSK | Save
  • Next-generation sequencing of 487 esophageal adenocarcinomas reveals independently prognostic genomic driver alterations and pathways
    Journal Article

    Sihag, S.; Nussenzweig, S. C.; Walch, H. S.; Hsu, M.; Tan, K. S.; Sanchez-Vega, F.; Chatila, W. K.; De La Torre, S. A.; Patel, A.; Janjigian, Y. Y.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic alterations in colitis-associated cancers in comparison to those found in sporadic colorectal cancer and present in precancerous dysplasia
    Meeting Abstract

    Chatila, W. K.; Walch, H. S.; Benhamida, J.; Hechtman, J. F.; Barriga, F. M.; Kundra, R.; Ismalgeci, D.; Miller, V. A.; Ganesh, K.; Faleck, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save